Koyfin Home > Directory > Health Care > Adma Biologics

Adma Biologics Price Chart ADMA

Historical daily share price chart and data for Adma Biologics since 2013 adjusted for splits and dividends. The latest closing price for Adma Biologics as of September 30, 2020 is $2.39.
  • In 2020 the stock opened at $4.04 and closed at $2.39 for a loss of -69% YTD.
  • In 2019 the stock opened at $2.38 and closed at $4.00 for a gain of 40%.
  • In 2018 the stock opened at $3.22 and closed at $2.39 for a loss of -35%.
  • In 2017 the stock opened at $5.13 and closed at $3.21 for a loss of -60%.
View Chart On Koyfin

Adma Biologics Summary

Stock Symbol: ADMA

Adma Biologics Company Info

ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical trials for the treatment of primary immune deficiency disease. The company also offers Nabi-HB, a hyperimmune globulin for the treatment of acute exposure; and Bivigam, an intravenous immune globulin for the treatment of primary humoral immunodeficiency. In addition, it operates source plasma collection facilities in Norcross, Marietta, and Kennesaw, Georgia. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
1336.32 %
30D Volatility
Hedge Fund Held
23.18 %

Last 10 Days of ADMA Prices